No Data
No Data
Solo Brands (DTC) Upgraded to Strong Buy: Here's Why
Solo Brands Inc Poised for Growth: Buy Rating Reaffirmed Amid Positive Sales Trends and Market Underappreciation
Express News | Shares of Companies Within the Broader Consumer Discretionary Sector Are Trading Higher Following Recent CPI Data
Q1 Leisure Products Earnings: Solo Brands (NYSE:DTC) Impresses
Defence Therapeutics Secures NOL From Health Canada For Phase I Trial of AccuTOX
Defence Therapeutics (DTC.CN), a Canadian biopharmaceutical company, on Monday said it secured a No Objection Letter (NOL) from Health Canada for its clinical trial of its AccuTOX cancer therapyThe tr
President of Solo Brands Christopher Metz Buys 150% More Shares